Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724243 | SCV000226569 | uncertain significance | not provided | 2014-12-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724243 | SCV000243506 | likely benign | not provided | 2020-04-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22161988, 21309039) |
Labcorp Genetics |
RCV001083507 | SCV000284694 | benign | Tuberous sclerosis 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564681 | SCV000675370 | likely benign | Hereditary cancer-predisposing syndrome | 2018-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001083507 | SCV002040065 | likely benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000564681 | SCV002530957 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-01-21 | criteria provided, single submitter | curation | |
Prevention |
RCV003407435 | SCV004107288 | uncertain significance | TSC1-related disorder | 2023-03-02 | criteria provided, single submitter | clinical testing | The TSC1 c.2077G>C variant is predicted to result in the amino acid substitution p.Asp693His. Functional studies of this variant by immunoblot analysis were inconclusive (Table 1, Hoogeveen-Westerveld et al. 2012. PubMed ID: 22161988). This variant is reported in 1 of ~251,000 alleles in gnomAD (http://gnomad.broadinstitute.org/variant/9-135779169-C-G) and has conflicting interpretations of benign, likely benign, and uncertain significance (https://preview.ncbi.nlm.nih.gov/clinvar/variation/64734/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
All of Us Research Program, |
RCV000054914 | SCV004840459 | uncertain significance | Tuberous sclerosis syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing | This missense variant replaces aspartic acid with histidine at codon 693 of the TSC1 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). A functional study has shown that the variant did not affect TSC1 stability, TSC1/TSC2 complex interaction or mTORC1 activity (PMID: 22161988). To our knowledge, this variant has not been reported in individuals affected with tuberous sclerosis complex in the literature. This variant has been identified in 1/251234 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Tuberous sclerosis database |
RCV000054914 | SCV000083129 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |